Baxter International (BAX) Current Deferred Revenue (2021 - 2024)

Baxter International (BAX) has 4 years of Current Deferred Revenue data on file, last reported at $171.0 million in Q4 2024.

• On a quarterly basis, Current Deferred Revenue rose 1.18% year-over-year to $171.0 million in Q4 2024; TTM through Dec 2024 was $171.0 million, a 1.18% increase from a year earlier, with the FY2024 full-year figure at $171.0 million, up 1.18% from the prior year.
• Current Deferred Revenue for Q4 2024 stood at $171.0 million, up from $169.0 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for BAX reached as high as $196.0 million in Q4 2021 and fell as low as $169.0 million in Q4 2023.
• Historically, Current Deferred Revenue has averaged $177.2 million across 4 years, with a median of $172.0 million in 2022.
• Across the five-year window, Current Deferred Revenue retreated 11.73% in 2022 and rose 1.18% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $196.0 million in 2021, then declined by 11.73% to $173.0 million in 2022, then fell by 2.31% to $169.0 million in 2023, then increased by 1.18% to $171.0 million in 2024.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $171.0 million in Q4 2024, $169.0 million in Q4 2023, and $173.0 million in Q4 2022.